Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Vycor Medical (VYCO) Short-Term Debt issuances (2022 - 2023)

Vycor Medical (VYCO) has disclosed Short-Term Debt issuances for 2 consecutive years, with $32879.0 as the latest value for Q3 2023.

  • Quarterly Short-Term Debt issuances fell 7.64% to $32879.0 in Q3 2023 from the year-ago period, while the trailing twelve-month figure was -$13425.0 through Sep 2023, changed N/A year-over-year, with the annual reading at -$6611.0 for FY2022, 0.66% up from the prior year.
  • Short-Term Debt issuances for Q3 2023 was $32879.0 at Vycor Medical, up from -$7986.0 in the prior quarter.
  • The five-year high for Short-Term Debt issuances was $35600.0 in Q3 2022, with the low at -$25003.0 in Q4 2022.